Porscha Johnson, PharmD, CPGx’s Post

View profile for Porscha Johnson, PharmD, CPGx, graphic

Oncology MSL | Medical Oncology/Pharmacogenomics SME & Consultant • Professional Speaker | 40 Under 40 in Cancer • Marquis Who’s Who for Excellence in Oncology Pharmacy

📣 NEXT UP‼️ "Navigating the Complexities and Controversies of Integrative Molecular Strategies in Oncology” sponsored by GenomeWeb and Precision Medicine Online ✨This webinar is Part 2 of a two-part molecular tumor board Spring series: https://lnkd.in/eG-vUduY. If you missed Part 1 (5/7), it’s now available on-demand!! 🗓️: Thursday, May 16th 🕐: 1-2 pm EST 💻 REGISTER HERE: https://lnkd.in/eJYQkpJs The advent of precision oncology has transformed the therapeutic landscape for patients, presenting a paradigm shift from one-size-fits-all approaches to individualized treatment strategies. This presentation recognizes the intricate balance between the potential of various assays to guide treatment decisions and the controversies surrounding their interpretation and clinical utility. We highlight the critical importance of Variant Allele Frequency (VAF) as a biomarker for tumor burden and treatment response, as well as explore the burgeoning field of Molecular Residual Disease (MRD) assays with a focused lens on their application in solid tumors. In addition, the concurrent application of tissue-based and liquid-based Next-Generation Sequencing (NGS) testing represents a cornerstone in the evolution of diagnostic modalities. By weaving together the threads of sequencing, VAF, and MRD assays, our presentation aims to feature the synergy of these technologies in advancing precision oncology, while acknowledging the challenges and debates that shape this dynamic field. Clarified Precision Medicine Howard McLeod Derrick Haslem Ben Kong Trevor Christ

Navigating the Complexities and Controversies of Integrative Molecular Strategies in Oncology

Navigating the Complexities and Controversies of Integrative Molecular Strategies in Oncology

event.on24.com

To view or add a comment, sign in

Explore topics